Φορτώνει......
Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors
PURPOSE: To describe patient characteristics and treatment patterns among early initiators of proprotein convertase subtilisin/kexin type nine inhibitors (PCSK9is) who initiated treatment within the first 6 months of market availability. PATIENTS AND METHODS: This retrospective cohort study used IQV...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Vasc Health Risk Manag |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6292243/ https://ncbi.nlm.nih.gov/pubmed/30573963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S180496 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|